Does ALEMTUZUMAB Cause Neoplasm? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Neoplasm have been filed in association with ALEMTUZUMAB (Campath). This represents 0.1% of all adverse event reports for ALEMTUZUMAB.
10
Reports of Neoplasm with ALEMTUZUMAB
0.1%
of all ALEMTUZUMAB reports
3
Deaths
4
Hospitalizations
How Dangerous Is Neoplasm From ALEMTUZUMAB?
Of the 10 reports, 3 (30.0%) resulted in death, 4 (40.0%) required hospitalization.
Is Neoplasm Listed in the Official Label?
Yes, Neoplasm is listed as a known adverse reaction in the official FDA drug label for ALEMTUZUMAB.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Neoplasm?
ADALIMUMAB (513)
OCTREOTIDE (366)
RITUXIMAB (323)
LENALIDOMIDE (242)
CYCLOPHOSPHAMIDE (221)
BEVACIZUMAB (207)
INFLIXIMAB (201)
ETANERCEPT (194)
RIBOCICLIB (194)
METHOTREXATE (165)
Which ALEMTUZUMAB Alternatives Have Lower Neoplasm Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET